HerbertStuart BlockBarafMDFACP, MACR
Rheumatology • Bethesda, MDCrystal Related
Special Volunteer, NIAMS
Dr. Baraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Edgemoor Ln
Bethesda, MD 20814
Education & Training
Duke University HospitalFellowship, Rheumatology, 1976 - 1978
George Washington UniversityResidency, Internal Medicine, 1973 - 1976
State University of New York Downstate Medical Center College of MedicineClass of 1973
University of MichiganBachelor of Science, 1965 - 1969
Certifications & Licensure
MD State Medical License 1978 - 2026
DC State Medical License 1974 - 2013
NC State Medical License 1976 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Innovation in Clinical Medicine Award American College of Rheumatology, 2022
- Herbert Baraf Excellence in Arthritis Care Award (inaugural recipient) Arthritis Foundation - Metro DC, 2022
- Paulding Phelps Award American College of Rheumatology, 2014
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsThe COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi
Rheumatology. 2024-04-02 - 2 citationsLong-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.Alan Kivitz, Alvin F Wells, Juan I Vargas, Herbert S B Baraf, Maureen Rischmueller
Rheumatology and Therapy. 2023-08-01 - 4 citationsExpert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri
Current Rheumatology Reports. 2022-01-01
Press Mentions
Gout: Combining 2 Existing Drugs Doubles Treatment Success in New StudyMay 20th, 2021
Practice & Society Donations Advance Advocacy Efforts for Rheumatologists & PatientsOctober 3rd, 2019- Private Practice in Rheumatology: Winners & Losers in the Workforce Numbers GameJuly 25th, 2018
- Join now to see all
Professional Memberships
- Master
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
